The Need for Cardiovascular Risk Factor Prevention in Cardio-Oncology
Authors:
- Giacomo TiniGTGiacomo Tini
- Matteo SarocchiMSMatteo Sarocchi
- Pietro AmeriPAPietro Ameri
- Eleonora ArboscelloEAEleonora Arboscello
- Paolo SpallarossaPSPaolo Spallarossa
- 1 April 2019
- journal article
- letter
- Published by Elsevier in JACC: Heart Failure
- Vol. 7 (4) , 367-368
Abstract
No abstract availableThis publication has 3 references indexed in Scilit:
- A recommended practical approach to the management of anthracycline-based chemotherapy cardiotoxicityJournal of Cardiovascular Medicine, 2016
- Pre-existing arterial hypertension as a risk factor for early left ventricular systolic dysfunction following (R)-CHOP chemotherapy in patients with lymphomaJournal of the American Society of Hypertension, 2014
- Congestive Heart Failure in Older Women Treated With Adjuvant Anthracycline Chemotherapy for Breast CancerJournal of Clinical Oncology, 2007